How SS-31 works
SS-31 concentrates in the inner mitochondrial membrane where it binds cardiolipin, stabilising cristae architecture and protecting cytochrome c from peroxidation. Electron transport becomes less leaky, so ATP output rises and reactive oxygen species fall.
Reported benefits
- More efficient ATP production
- Reduced oxidative stress load
- Protection of cristae structure under strain
- Improved endurance and recovery capacity
Reported side effects
Effects reported in published trials, case reports or post-market surveillance. Individual response varies; this list is educational and not exhaustive.
- Injection-site redness or itching
- Headache and light-headedness
- Transient fatigue after early doses
- Gastrointestinal upset reported anecdotally
Regulatory status & sources
In clinical trials
Not FDA approved. Elamipretide (SS-31) has been studied in mitochondrial myopathy, Barth syndrome and dry AMD.
Safety note
SS-31 is presented here for research and educational purposes only. It is not offered for human consumption and nothing on this page is medical advice or a dosing protocol. Read the full safety and disclaimer page.